Attendance and weight outcomes in 4754 adults referred over 6 months to a primary care/commercial weight management partnership scheme

Clinical Obesity

Volumn 2, Issue 1-2, 2012, Pages 6-14

  Stubbs, R J ^a   Brogelli, D J ^a   Pallister, C J ^a   Whybrow, S ^b   Avery, A J ^a   Lavin, J H ^a  

^a SLIMMING WORLD   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Commercial weight management organization; Effectiveness; Obesity

Indexed keywords

ADULT; ARTICLE; BODY MASS; FEMALE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; POPULATION RESEARCH; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; SEX DIFFERENCE; TREATMENT OUTCOME; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 84876937713     PISSN: None     EISSN: 17588111     Source Type: Journal    
DOI: 10.1111/j.1758-8111.2012.00040.x     Document Type: Article

References (39)

1. HM Government. Healthy Lives, Healthy People: Our Strategy for Public Health in England. HM Stationary Office: London, 2010.
2. Department of Health. HealthyWeight, Healthy Lives; A Cross Government Strategy for England. Department of Health: London,2008.
3. Brownell KD, Marlatt GA, Lichtenstein E, Wilson GT. Understanding and preventing relapse. Am Psychol 1986; 41: 765-782.
4. Brownell KD, Wadden TA. The heterogeneity of obesity: fitting treatments to individuals. Behav Ther 1991; 22: 153-177.
5. Elfhag K, Rössner S. Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obes Rev 2005; 6: 67-85.
6. Stubbs J, Whybrow S, Teixeira P et al. Problems in identifying predictors and correlates of weight loss and maintenance:implications for weight control therapies based on behaviour change. Obes Rev 2011; 12: 688-708.
7. Wing RR, Hill JO. Successful weight loss maintenance. Annu Rev Nutr 2001; 21: 323-341.
8. Behavioural Insights Team. Applying Behavioural Insight to Health. The Cabinet Office: London, 2010.
9. Grist M. Steer: Mastering Our Behaviour Through Instinct, Environment and Reason. RSA Projects: London,2010. [WWW document]. URL https://update.cabinetoffice.gov.uk/resource-library/applying-behavioural-insight-health (accessed March 2012).
10. Swanton K, Frost M. Lightening the Load: Tackling Overweight and Obesity. National Heart Forum: London, 2007.
11. Stubbs RJ, Pallister C, Whybrow S, Avery A, Lavin JH. Weight outcomes for 34,271 participants in a commercial/primary care weight management partnership scheme. Obes Facts 2011; 4: 113-120.
12. Lloyd A, Khan R. Evaluation of healthy choices: a commercial weight loss programme commissioned by the NHS. Perspect Public Health 2011; 131: 177-183.
13. Truby H, Baic S, deLooy A et al. Randomised controlled trial of four commercial weight loss programmes in the UK: initial findings from the BBC 'diet trials'. BMJ 2006; 332: 1309-1314.
14. The Counterweight Project Team. Evaluation of the Counterweight Programme for obesity management in primary care: a starting point for continuous improvement. Br J Gen Pract 2008;58: 548-554.
15. Jebb SA, Ahern AL, Olson AD et al. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet 2011; 378:1485-1492.
16. Ahern AL, Olson AD, Aston LM, Jebb SA. Weight Watchers on prescription: an observational study of weight change among adults referred to Weight Watchers by the NHS. BMC Public Health 2011; 11: 434-438.
17. Lavin JH, Avery A, Whitehead SM et al. Feasibility and benefits of implementing a Slimming on Referral service in primary care using a commercial weight management partner. Public Health 2006; 120: 872-881.
18. Bye C, Avery A, Lavin J. Tackling obesity in men - preliminary evaluation of men-only groups within a commercial slimming organization. J Hum Nutr Diet 2005; 18: 391-394.
19. Streiner DL. The case of the missing data: methods of dealing with dropouts and other research vagaries. Can J Psychol 2002;47: 68-75.
20. Jolly K, Lewis A, Beach J et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: Lighten Up randomised controlled trial. BMJ 2011; 343: d6500.
21. Heshka S, Anderson JW, Atkinson RL et al. Weight loss with self-help compared with a structured commercial program: a randomized trial. JAMA 2003; 289: 1792-1798.
22. National Institute for Health and Clinical Excellence. Obesity:The Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children. Department of Health: London, 2006.
23. Linde JA, Jeffery RW, Levy RL, Pronk NP, Boyle RG. Weight loss goals and treatment outcomes among overweight men and women enrolled in a weight loss trial. Int J Obes Relat Metab Disord 2005; 29: 1002-1005.
24. Handjieva-Darlenska T, Handjiev S, Larsen TM et al. Initial weight loss on an 800-kcal diet as a predictor of weight loss success after 8 weeks: the Diogenes study. Eur J Clin Nutr 2010; 64:994-999.
25. Hansen DL, Astrup A, Toubro S et al. Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Int J Obes Relat Metab Disord 2001; 25: 496-501.
26. Institute of Medicine. Weighing the Options: Criteria for Evaluating Weight Management Programmes. National Academy Press: Washington D.C., 1995.
27. Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Arch Intern Med 2001;161: 218-227.
28. Wadden TA, Sarwer DB. Behavioral treatment of obesity:new approaches to an old disorder. In: Goldstein D (ed.). The Management of Eating Disorders. Humana Press: Totowa, NJ,1999, pp. 173-196.
29. Glenny AM, O'Meara S, Melville A, Sheldon TA, Wilson C. The treatment and prevention of obesity: a systematic review of the literature. Int J Obes Relat Metab Disord 1995; 19: 893-901.
30. Powell C, Lavin J, Russell J, Barker M. Factors associated with successful weight loss and attendance at commercial slimming group. Int J Obes Relat Metab Disord 2004; 28: S144.
31. Teixeira PJ, Going SB, Sardinha LB, Lohman TG. A review of psychosocial pre-treatmant predictors of weight control. Obes Rev 2005; 6: 43-65.
32. Wadden TA, Foster GD. Behavioral treatment of obesity. Med Clin North Am 2000; 84: 441-461.
33. Hall KD, Jordan PN. Modeling weight-loss maintenance to help prevent body weight regain. Am J Clin Nutr 2008; 88: 1495-1503.
34. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995; 332: 621-628.
35. Stubbs RJ, Hughes DA, Johnstone AM et al. Interactions between energy intake and expenditure in the development and treatment of obesity. In: Medeiro-Neto G, Halpern A, Bouchard C (eds). Progress in Obesity Research 9. John Libbey Eurotext Ltd: Surrey, 2003, pp. 418-425.
36. Padwal R, Li SK, Lau DC. Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Int J Obes Relat Metab Disord 2003;27: 1436-1446.
37. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27: 155-161.
38. Wirth A, Krause J. Long-term weight loss with sibutramine:a randomized controlled trial. JAMA 2001; 286: 1331-1339.
39. British National Formulary. No 62 (September 2011) [WWW document]. URL http://bnf.org/bnf/bnf/current/128644.htm (accessed March 2012).